RESPIRATORY DISEASE TESTING MARKET ANALYSIS (2020-2027) - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

RESPIRATORY DISEASE TESTING MARKET ANALYSIS (2020-2027)

Description:

Read here the market research report on the “Respiratory Disease Testing Market" published by CMI Team – PowerPoint PPT presentation

Number of Views:7
Date added: 5 November 2020
Slides: 21
Provided by: kunalbhuta
Category: Other

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: RESPIRATORY DISEASE TESTING MARKET ANALYSIS (2020-2027)


1
  • Coherent Market Insights
  • Market Research and Business Consulting Services
  • https//www.coherentmarketinsights.com/
  • COVID-19 Impact Tracker

2
RESPIRATORY DISEASE TESTING MARKET ANALYSIS
(2020-2027)
  • Respiratory Disease Testing Market, By Test Type
    (Imaging Test, Spirometry, Peak Flow Test, Blood
    Gas Test, Lung Volume Test, Others), By End User
    (Hospitals, Physician Offices, Clinical
    Laboratories), and By Region (North America,
    Latin America, Europe, Asia Pacific, Middle East
    Africa) - Size, Share, Outlook, and Opportunity
    Analysis, 2020 - 2027

3
  • Respiratory disease is a medical condition that
    affects the structure and organs associated with
    respiration or breathing. Based on anatomical
    features, the respiratory system has been
    segmented into upper respiratory tract and lower
    respiratory tract. The upper respiratory tract
    comprises pharynx, larynx and nasal passages,
    while the lower respiratory tract includes
    trachea, lungs and bronchi.

4
Statistics
  • The global respiratory disease testing market is
    estimated to account for US 3,738.8 Mn in terms
    of value by the end of 2027.

5
Global Respiratory Disease Testing Market Drivers
  • Increasing prevalence of respiratory diseases is
    expected to propel growth of the global
    respiratory disease testing market over the
    forecast period. For instance, according to a
    report by Global Initiative For Chronic
    Obstruction Diseases 2018 report, COPD is
    expected to result in 4.5 million global deaths
    annually by 2030.
  • Moreover, increasing geriatric population is also
    expected to aid in growth of the market. For
    instance, according to the World Health
    Organization, geriatric population is expected to
    reach 2 billion by 2050, up from 900 million in
    2015.

6
Statistics
  • North America held dominant position in the
    global respiratory disease testing market in
    2019, accounting for 34.6 share in terms of
    value, followed by Asia Pacific and Europe,
    respectively.

7
Figure 1 Global Respiratory Disease Testing
Market Share () Value, By Region, 2019
8
Global Respiratory Disease Testing Market
Restraints
  • Low adoption rate of digital radiography is
    expected to hinder the market growth. Digital
    radiography systems have witnessed low adoption
    rate as these are more expensive than analog
    radiography systems (US 11,000 US 22,000).
    The cost of digital radiography equipment ranges
    from US 100,000 to US 130, 000.
  • Moreover, inaccuracy of rapid diagnostic tests is
    also expected to hinder growth of the market. For
    instance, in May 2020, a study by researchers at
    New York University found that a COVID-19 rapid
    diagnostic made by Abbott Laboratories failed to
    detect up to 48 of positive results.

9
(No Transcript)
10
Global Respiratory Disease Testing Market
Opportunities  
  • Increasing prevalence of lung cancer is expected
    to offer lucrative growth opportunities for
    players in the global respiratory disease testing
    market. For instance, according to The American
    Cancer Society, in 2020, the U.S. is expected to
    witness around 228,820 new cases of lung cancer
    and around 135,720 deaths due to the disease.
  • Moreover, increasing number of smokers is also
    expected to aid in growth of the market. For
    instance, according to the World Health
    Organization, 1.337 billion people smoked tobacco
    worldwide in 2018.  

11
Statistics
  • The global respiratory disease testing market was
    valued at US 2,831.0 Mn in 2019 and is forecast
    to reach a value of US 3,738.8 Mn by 2027 at
    a CAGR of 3.5 between 2020 and 2027.

12
  • Figure 2 Global Respiratory Disease Testing
    Market Value (US Mn), 2016 2027

13
Market Trends/Key Takeaways
  • Increasing air pollution is boosting growth of
    the market. For instance, according to Health
    Effects Institute estimates (provided by
    University of Texas at Austin), air pollution was
    the fifth leading risk factor for mortality
    worldwide in 2019.
  • Major players in the market are focused on
    launching new products to expand their product
    portfolio. For instance, in March 2020, Quest
    Diagnostics announced to launch a coronavirus
    (COVID-19) test service that aids the presumptive
    detection of nucleic acid in respiratory
    specimens of patients meeting the Centers for
    Disease Control and Preventions clinical
    criteria for COVID-19 testing.

14
Regulations
  • Occupational Safety and Health Administration
    (OSHA), the U.S. Department of Labor, stated in
    2013 that healthcare professionals conducting
    occupational spirometry testing should complete
    initial lung function testing course approved by
    National Institute for Occupational Safety and
    Health (NIOSH). It also recommended that a lung
    function testing equipment should have the
    following features meet accuracy and precision
    criteria set by American Thoracic
    Society/European Respiratory Society and
    instrument should have real time graphical
    display.

15
Global Respiratory Disease Testing Market
Competitive Landscape
  • Major players operating in the global respiratory
    disease testing market include, CareFusion
    Corporation, Carestream Health, Inc., COSMED,
    Futuremed America, Inc., GE Healthcare, MGC
    Diagnostics Corporation, ndd Medical
    Technologies, Inc., Nihon Kohden Corporation,
    Perkin Elmer, Inc., Philips Healthcare, and Quest
    Diagnostics.

16
Global Respiratory Disease Testing Market Key
Developments
  • Major players in the market are focused on
    launching new products to expand their product
    portfolio. For instance, in June 2020, Carestream
    Health, Inc. launched Carestream NDT INDUSTREX
    Digital Viewing Software Version 5.2, a
    non-destructive testing (NDT) technology.

17
  • Request Sample Report
  • Request Customization
  • Download PDF Brochure
  • Talk to Analyst
  • Buy Now
  • Reference https//www.coherentmarketinsights.com/
    market-insight/respiratory-disease-testing-market-
    4030

18
About Us
  • Coherent Market Insights is a global market
    intelligence and consulting organization focused
    on assisting our plethora of clients achieve
    transformational growth by helping them make
    critical business decisions.
  • What we provide
  • Customized Market Research Services
  • Industry Analysis Services
  • Business Consulting Services
  • Market Intelligence Services
  • Long term Engagement Model
  • Country Specific Analysis

19
Contact Us
  • Mr. Shah
  • Coherent Market Insights Pvt.Ltd.
  • Address 1001 4th Ave, 3200 Seattle, WA 98154,
    U.S.
  • Phone 1-206-701-6702
  • Email sales_at_coherentmarketinsights.com

20
  • Thank You!
  • Kindly follow CMI Social Media
    Profiles for the latest company updates
  • Facebook
  • Linkedin
  • Twitter
  • https//www.coherentmarketinsights.com/
About PowerShow.com